Yelverton Tegner

Prof. Dr. Yelverton Tegner

Division of Medical Sciences, Department of Health Sciences, Lulea University of Technology, 971 87 Lulea, Sweden
orcid

Research Focus & Metrics

Academic Career Length

44Years (1983-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 1985 in Clinical Orthopaedics and Related Research
Verified
Journal Article
Closed access
Yelverton TegnerYelverton Tegner
Yelverton Tegner
JLJack Lysholm
Jack Lysholm
Many different methods of evaluating disability after knee ligament injury exist. Most of them differ in design. Some are based on only patients' symptoms. Other include patients' symptoms, activity grading, performance in a test, and clinical findings. The rating in these evaluating systems can be either numerical, as in a score, or binary, with yes/no answers. Comparison between a symptom-related score and a score of more complex design showed that the symptom-related score gave a more differentiated picture of the disability. It was also shown that the binary rating system gave less detailed information than a score and that differences in a binary rating can depend on at what level the symptoms are regarded as "significant." A new activity grading scale, where work and sport activities were graded numerically, was constructed as complement to the functional score. When evaluating knee ligament injuries, stability testing, functional knee score, performance test, and activity grading are all important. However, the relative importance varies during the course of treatment, and therefore they should not all be included in one and the same score.

4 March 2009 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
KBKaren K. Briggs
Karen K. Briggs
JLJack Lysholm
Jack Lysholm
Yelverton TegnerYelverton Tegner
Yelverton Tegner
WRWilliam G. Rodkey
William G. Rodkey
MKMininder S. Kocher
Mininder S. Kocher
JSJ. Richard Steadman
J. Richard Steadman
Background: In 1982, the Lysholm score was first published as a physician-administered score in the American Journal of Sports Medicine. The Tegner activity scale was published in 1985. Hypothesis: The Lysholm and Tegner scores are valid as patient-administered scores and responsive at early time points after treatment of anterior cruciate ligament tears. Study Design: Cohort study (Diagnosis); Level of evidence, 1. Methods: All patients were treated for an anterior cruciate ligament tear. For responsiveness, the Lysholm score (n = 1075) and Tegner activity level (n = 505) were measured preoperatively and 6, 9, 12, and 24 months postoperatively. For test-retest (n = 50), scores were measured at 2 years postoperatively and again within 4 weeks by questionnaire. For criterion validity (n = 170), patients completed the Short Form-12 and the International Knee Documentation Committee score in addition to Lysholm and Tegner instruments. For all other analyses, preoperative Lysholm score (n = 1783) or Tegner activity levels (n = 687) were collected. Results: There was acceptable test-retest reliability for both the Lysholm (intraclass correlation coefficient = 0.9) and Tegner (intraclass correlation coefficient = 0.8) scores. The minimum detectable change for Lysholm was 8.9 and for Tegner was 1. The Lysholm demonstrated acceptable internal consistency. The Lysholm correlated with the International Knee Documentation Committee (r = .8) and the Short Form-12 (r = .4), and Tegner correlated with the Short Form-12 (r = .2). Both scores had acceptable floor and ceiling effects and all hypotheses were significant. The Lysholm and Tegner were responsive to change at each of the time points. Conclusion: After 25 years of changes in treatment of anterior cruciate ligament injuries, the Lysholm knee score and the Tegner activity scale demonstrated acceptable psychometric parameters as patient-administered scores and showed acceptable responsiveness to be used in early return to function after anterior cruciate ligament treatment.

1 June 2014 in JAMA Neurology
Verified
Journal Article
Open access
PDF file
PSPashtun Shahim
Pashtun Shahim
Yelverton TegnerYelverton Tegner
Yelverton Tegner
DWDavid H. Wilson
David H. Wilson
JRJeffrey Randall
Jeffrey Randall
TSTobias Skillbäck
Tobias Skillbäck
HZHenrik Zetterberg
Henrik Zetterberg
Quiz Ref ID Concussion in athletes practicing contact sports such as ice hockey, American football, and boxing is a growing problem worldwide.1-3 The term is often used interchangeably with mild traumatic brain injury (TBI). During recent years, many professional athletes have retired owing to chronic symptoms after repeated concussions.4 An international consensus statement defined concussion as a complex pathophysiological process affecting the brain, induced by traumatic biomechanical forces.5 Mild concussion causes no loss of consciousness, but many other symptoms such as dizziness, nausea, reduced attention and concentration, memory problems, and headache may occur. More severe concussion also causes unconsciousness. The pathophysiology underlying concussion is an acute disturbance of neuronal function together with damage to neuronal and glial cells, which may have both subacute and chronic consequences.6 Most concussions resolve within days to weeks, but 10% to 15% remain symptomatic more than 1 year after injury.7,8 The danger of developing chronic or even progressive symptoms has been linked to repeated concussions before the brain has recovered properly.4 Tools to detect and monitor injury to the central nervous system (CNS) due to concussion are therefore of great importance and could objectively inform decisions on when return to play (RTP) may be safe.

7 November 2016 in Scientific Reports
Verified
Journal Article
Open access
PDF file
PSPashtun Shahim
Pashtun Shahim
MGMagnus Gren
Magnus Gren
VLVictor Liman
Victor Liman
UAUlf Andreasson
Ulf Andreasson
NNNiklas Norgren
Niklas Norgren
KBKaj Blennow
Kaj Blennow
Axonal white matter injury is believed to be a major determinant of adverse outcomes following traumatic brain injury (TBI). We hypothesized that measurement of neurofilament light protein (NF-L), a protein found in long white-matter axons, in blood samples, may serve as a suitable biomarker for neuronal damage in TBI patients. To test our hypotheses, we designed a study in two parts: i) we developed an immunoassay based on Single molecule array technology for quantification of NF-L in blood, and ii) in a proof-of-concept study, we tested our newly developed method on serial serum samples from severe TBI (sTBI) patients (n = 72) and controls (n = 35). We also compared the diagnostic and prognostic utility of NF-L with the established blood biomarker S100B. NF-L levels were markedly increased in sTBI patients compared with controls. NF-L at admission yielded an AUC of 0.99 to detect TBI versus controls (AUC 0.96 for S100B), and increased to 1.00 at day 12 (0.65 for S100B). Importantly, initial NF-L levels predicted poor 12-month clinical outcome. In contrast, S100B was not related to outcome. Taken together, our data suggests that measurement of serum NF-L may be useful to assess the severity of neuronal injury following sTBI.

9 May 2017 in Neurology
Verified
Journal Article
Closed access
PDF file
PSPashtun Shahim
Pashtun Shahim
HZHenrik Zetterberg
Henrik Zetterberg
Yelverton TegnerYelverton Tegner
Yelverton Tegner
KBKaj Blennow
Kaj Blennow
Objective: To evaluate whether the axonal protein neurofilament light (NFL) in serum is a sensitive biomarker to detect subtle brain injury or concussion in contact sports athletes. Methods: Two prospective cohort studies involving (1) 14 Swedish amateur boxers who underwent fluid biomarker assessments at 7–10 days after bout and after 3 months of rest from boxing and (2) 35 Swedish professional hockey players who underwent blood biomarker assessment at 1, 12, 36, and 144 hours after concussion and when the players returned to play were performed. Fourteen healthy nonathletic controls and 12 athletic controls were also enrolled. Serum NFL was measured using ultrasensitive single molecule array technology. Results: Serum NFL concentrations were increased in boxers 7–10 days after bout as compared to the levels after 3 months rest as well as compared with controls (p = 0.0007 and p < 0.0001, respectively). NFL decreased following 3 months of rest, but was still higher than in controls (p < 0.0001). Boxers who received many (>15) hits to the head or were groggy after bout had higher concentrations of serum NFL as compared to those who received fewer hits to the head (p = 0.0023). Serum NFL increased over time in hockey players, and the levels returned to normal at return to play. Importantly, serum NFL could separate players with rapidly resolving postconcussion symptoms (PCS) from those with prolonged PCS. Conclusions: The results from these 2 independent cohort studies suggest that serum NFL is a highly sensitive biomarker for concussion.

1 March 1986 in The American Journal of Sports Medicine
Verified
Journal Article
Closed access
PDF file
Yelverton TegnerYelverton Tegner
Yelverton Tegner
JLJack Lysholm
Jack Lysholm
MLMarketta Lysholm
Marketta Lysholm
JGJan Gillquist
Jan Gillquist
A performance test simulating components of sports was devised to evaluate dysfunction after ACL injury. The test included a one-leg hop, running in a figure of eight (straight running and turn running measured sep arately), running up and down a spiral staircase, and running up and down a slope. Twenty-six men with ACL injury, most of them soccer players, and 66 uninjured male soccer players were studied. Patients with ACL injury performed signifi cantly less well than the uninjured players. Test items of special interest were turn running in the figure of eight, stair running, and slope running, all of which place high demand on the knee. It is concluded that a performance test of this design is useful for monitoring rehabilitation and for evaluating the patient's condition. Before sports can be resumed at the original level, normal strength and normal per formance should be regained.